Filing Flows

Filing Flows › Verrica Pharmaceuticals (VRCA) › Who owns the stock

Who owns Verrica Pharmaceuticals (VRCA) stock

37 funds reported Verrica Pharmaceuticals (VRCA) shares in their latest 13F filings, worth $29.4M in all. The largest holder is Caligan Partners LP ($5.7M). Last quarter 14 funds added to their stakes and 14 cut them.

Largest holders of VRCA (13F)Largest holders of VRCA (13F)Caligan Partners LP$5.7MCannell Capital LLC$4.8MAffinity Asset Advisors, LLC$4.3MVelan Capital Investment Manageme…$2.9MArmistice Capital, LLC$2.6MBoothbay Fund Management, LLC$1.7MVanguard Capital Management LLC$1.7MMariner, LLC$1.3MVanguard Group$1.1MGeode Capital Management, LLC$846K

Largest holders (13F)

FundSharesValueChangeQuarter
Caligan Partners LP923,910$5.7Munchanged2026-06-30
Cannell Capital LLC783,923$4.8Mincrease2026-06-30
Affinity Asset Advisors, LLC707,338$4.3Munchanged2026-06-30
Velan Capital Investment Management LP471,559$2.9Munchanged2026-06-30
Armistice Capital, LLC426,304$2.6Mdecrease2026-06-30
Boothbay Fund Management, LLC280,734$1.7Munchanged2026-06-30
Vanguard Capital Management LLC279,310$1.7Mincrease2026-06-30
Mariner, LLC207,230$1.3Mincrease2026-06-30
Vanguard Group138,194$1.1Mdecrease2025-12-31
Geode Capital Management, LLC138,160$846Kdecrease2026-06-30
BlackRock74,344$455Kincrease2026-06-30
Vanguard Fiduciary Trust70,173$429Kincrease2026-06-30
Two Sigma Investments, LP40,825$250Kdecrease2026-06-30
State Street28,916$177Kunchanged2026-06-30
Northern Trust26,996$165Kdecrease2026-06-30

Verrica Pharmaceuticals' latest quarter

Verrica Pharmaceuticals, Q2 2026: revenue $5.9M (-54% year over year), operating margin -223.4%, net loss $13.2M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most VRCA stock?

By the latest 13F filings: Caligan Partners LP ($5.7M); Cannell Capital LLC ($4.8M); Affinity Asset Advisors, LLC ($4.3M); Velan Capital Investment Management LP ($2.9M); Armistice Capital, LLC ($2.6M).

What is the short interest in VRCA?

192,613 shares were sold short at the 2026-10-15 settlement, -1.84% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.